Alcohol or Gut Microbiota

Who Is the Guilty?

Marica Meroni, Miriam Longo, Paola Dongiovanni

Research output: Contribution to journalReview article

Abstract

Alcoholic liver disease (ALD), a disorder caused by excessive alcohol intake represents a global health care burden. ALD encompasses a broad spectrum of hepatic injuries including asymptomatic steatosis, alcoholic steatohepatitis (ASH), fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). The susceptibility of alcoholic patients to develop ALD is highly variable and its progression to more advanced stages is strongly influenced by several hits (i.e., amount and duration of alcohol abuse). Among them, the intestinal microbiota and its metabolites have been recently identified as paramount in ALD pathophysiology. Ethanol abuse triggers qualitative and quantitative modifications in intestinal flora taxonomic composition, mucosal inflammation, and intestinal barrier derangement. Intestinal hypermeability results in the translocation of viable pathogenic bacteria, Gram-negative microbial products, and pro-inflammatory luminal metabolites into the bloodstream, further corroborating the alcohol-induced liver damage. Thus, the premise of this review is to discuss the beneficial effect of gut microbiota modulation as a novel therapeutic approach in ALD management.

Original languageEnglish
Article numberE4568
JournalInternational Journal of Molecular Sciences
Volume20
Issue number18
DOIs
Publication statusPublished - Sep 14 2019

Fingerprint

Alcoholic Liver Diseases
liver
Liver
alcohols
Alcohols
metabolites
Metabolites
Fibrosis
Alcoholic Fatty Liver
plants (botany)
Alcoholics
fibrosis
Disease Management
Gram-Negative Bacteria
Alcoholism
Hepatocellular Carcinoma
Health care
progressions
Ethanol
bacteria

Keywords

  • alcoholic liver disease
  • fecal microbiota transplantation
  • gut microbiota
  • gut-liver axis
  • intestinal permeability
  • leaky gut
  • target therapy
  • tight junctions

ASJC Scopus subject areas

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Cite this

Alcohol or Gut Microbiota : Who Is the Guilty? / Meroni, Marica; Longo, Miriam; Dongiovanni, Paola.

In: International Journal of Molecular Sciences, Vol. 20, No. 18, E4568, 14.09.2019.

Research output: Contribution to journalReview article

@article{c814572b5626411c9a5fe70975c4ba0e,
title = "Alcohol or Gut Microbiota: Who Is the Guilty?",
abstract = "Alcoholic liver disease (ALD), a disorder caused by excessive alcohol intake represents a global health care burden. ALD encompasses a broad spectrum of hepatic injuries including asymptomatic steatosis, alcoholic steatohepatitis (ASH), fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). The susceptibility of alcoholic patients to develop ALD is highly variable and its progression to more advanced stages is strongly influenced by several hits (i.e., amount and duration of alcohol abuse). Among them, the intestinal microbiota and its metabolites have been recently identified as paramount in ALD pathophysiology. Ethanol abuse triggers qualitative and quantitative modifications in intestinal flora taxonomic composition, mucosal inflammation, and intestinal barrier derangement. Intestinal hypermeability results in the translocation of viable pathogenic bacteria, Gram-negative microbial products, and pro-inflammatory luminal metabolites into the bloodstream, further corroborating the alcohol-induced liver damage. Thus, the premise of this review is to discuss the beneficial effect of gut microbiota modulation as a novel therapeutic approach in ALD management.",
keywords = "alcoholic liver disease, fecal microbiota transplantation, gut microbiota, gut-liver axis, intestinal permeability, leaky gut, target therapy, tight junctions",
author = "Marica Meroni and Miriam Longo and Paola Dongiovanni",
year = "2019",
month = "9",
day = "14",
doi = "10.3390/ijms20184568",
language = "English",
volume = "20",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "MDPI AG",
number = "18",

}

TY - JOUR

T1 - Alcohol or Gut Microbiota

T2 - Who Is the Guilty?

AU - Meroni, Marica

AU - Longo, Miriam

AU - Dongiovanni, Paola

PY - 2019/9/14

Y1 - 2019/9/14

N2 - Alcoholic liver disease (ALD), a disorder caused by excessive alcohol intake represents a global health care burden. ALD encompasses a broad spectrum of hepatic injuries including asymptomatic steatosis, alcoholic steatohepatitis (ASH), fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). The susceptibility of alcoholic patients to develop ALD is highly variable and its progression to more advanced stages is strongly influenced by several hits (i.e., amount and duration of alcohol abuse). Among them, the intestinal microbiota and its metabolites have been recently identified as paramount in ALD pathophysiology. Ethanol abuse triggers qualitative and quantitative modifications in intestinal flora taxonomic composition, mucosal inflammation, and intestinal barrier derangement. Intestinal hypermeability results in the translocation of viable pathogenic bacteria, Gram-negative microbial products, and pro-inflammatory luminal metabolites into the bloodstream, further corroborating the alcohol-induced liver damage. Thus, the premise of this review is to discuss the beneficial effect of gut microbiota modulation as a novel therapeutic approach in ALD management.

AB - Alcoholic liver disease (ALD), a disorder caused by excessive alcohol intake represents a global health care burden. ALD encompasses a broad spectrum of hepatic injuries including asymptomatic steatosis, alcoholic steatohepatitis (ASH), fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). The susceptibility of alcoholic patients to develop ALD is highly variable and its progression to more advanced stages is strongly influenced by several hits (i.e., amount and duration of alcohol abuse). Among them, the intestinal microbiota and its metabolites have been recently identified as paramount in ALD pathophysiology. Ethanol abuse triggers qualitative and quantitative modifications in intestinal flora taxonomic composition, mucosal inflammation, and intestinal barrier derangement. Intestinal hypermeability results in the translocation of viable pathogenic bacteria, Gram-negative microbial products, and pro-inflammatory luminal metabolites into the bloodstream, further corroborating the alcohol-induced liver damage. Thus, the premise of this review is to discuss the beneficial effect of gut microbiota modulation as a novel therapeutic approach in ALD management.

KW - alcoholic liver disease

KW - fecal microbiota transplantation

KW - gut microbiota

KW - gut-liver axis

KW - intestinal permeability

KW - leaky gut

KW - target therapy

KW - tight junctions

UR - http://www.scopus.com/inward/record.url?scp=85072540849&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072540849&partnerID=8YFLogxK

U2 - 10.3390/ijms20184568

DO - 10.3390/ijms20184568

M3 - Review article

VL - 20

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 18

M1 - E4568

ER -